Incyte & Lilly's Olumiant Gets Marketing Approval in Japan - Nasdaq

Incyte & Lilly's Olumiant Gets Marketing Approval in Japan - Nasdaq | marketing - Google News | July 04, 2017 at 08:53AM

Incyte & Lilly's Olumiant Gets Marketing Approval in Japan Nasdaq Incyte CorporationINCY and partner Eli Lilly and Company LLY announced that Japan's Ministry of Health, Labor and Welfare (MHLW) granted marketing approval for Olumiant (baricitinib) 2-mg and 4-mg tablets. The drug will be used for treating rheumatoid ... and more »

July 04, 2017 at 08:53AM | marketing - Google News
Incyte & Lilly's Olumiant Gets Marketing Approval in Japan - Nasdaq
marketing - Google News